{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:25:35Z","timestamp":1780997135556,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Holding SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018381","name":"Stiftung f\u00fcr Leberkrankheiten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhepr.2025.101452","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:33:43Z","timestamp":1746905623000},"page":"101452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7194-4541","authenticated-orcid":false,"given":"Karen Vagner","family":"Danielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5600-5623","authenticated-orcid":false,"given":"Jens Dahlgaard","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-4423","authenticated-orcid":false,"given":"Puria","family":"Nabilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-8564","authenticated-orcid":false,"given":"Thit Mynster","family":"Kronborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig Roman","family":"Siebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Guruprasad P.","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-7764","authenticated-orcid":false,"given":"S\u00f8ren","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8419-2104","authenticated-orcid":false,"given":"Flemming","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101452_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101452_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.jhepr.2025.101452_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002248","article-title":"Serelaxin as a potential treatment for renal dysfunction in cirrhosis: preclinical evaluation and results of a randomized phase 2 trial","volume":"14","author":"Snowdon","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhepr.2025.101452_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2021.08.016","article-title":"Terlipressin and the treatment of hepatorenal syndrome: how the CONFIRM trial moves the story forward","volume":"79","author":"Belcher","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jhepr.2025.101452_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00365520310008728","article-title":"Effect of terlipressin on blood volume distribution in patients with cirrhosis","volume":"39","author":"Kiszka-Kanowitz","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101452_bib8","doi-asserted-by":"crossref","first-page":"G313","DOI":"10.1152\/ajpgi.00328.2019","article-title":"Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial","volume":"318","author":"Israelsen","year":"2020","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhepr.2025.101452_bib9","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/hep.21901","article-title":"Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome","volume":"46","author":"Krag","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101452_bib10","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis","volume":"24","author":"Narahara","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib11","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1007\/s00330-020-07259-w","article-title":"Haemodynamic changes in cirrhosis following terlipressin and induction of sepsis\u2014a preclinical study using caval subtraction phase-contrast and cardiac MRI","volume":"31","author":"Chouhan","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhepr.2025.101452_bib12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1478-3231.2010.02322.x","article-title":"Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis","volume":"30","author":"Kalambokis","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101452_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.08.010","article-title":"Long-term continuous terlipressin infusion improves cardiac reserve in patients with decompensated cirrhosis","author":"Terbah","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/HEP.0000000000000691","article-title":"Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography","volume":"79","author":"Premkumar","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101452_bib15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.14309\/ajg.0000000000001847","article-title":"Cardiovascular mapping in cirrhosis from the compensated stage to hepatorenal syndrome: a magnetic resonance study","volume":"117","author":"Danielsen","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101452_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101452_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jhep.2016.07.021","article-title":"Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging","volume":"65","author":"Palaniyappan","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jhep.2018.05.037","article-title":"Multi-organ assessment of compensated cirrhosis patients using quantitative magnetic resonance imaging","volume":"69","author":"Bradley","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib19","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib20","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/MEG.0b013e32833a4822","article-title":"Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis","volume":"22","author":"Krag","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients","volume":"20","author":"M\u00f8ller","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.jhepr.2025.101452_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jgh.12709","article-title":"Acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"30","author":"Egerod Israelsen","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101452_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/apt.17195","article-title":"Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure","volume":"56","author":"Wong","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2025.101452_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","article-title":"Hepatorenal syndrome in cirrhosis","volume":"166","author":"Pose","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101452_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-024-07681-4","article-title":"Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis","volume":"51","author":"Wong","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhepr.2025.101452_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.17899","article-title":"Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis","volume":"59","author":"M\u00fccke","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2025.101452_bib27","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1097\/CCM.0b013e318246bd85","article-title":"Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation","volume":"40","author":"Prowle","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhepr.2025.101452_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.RVI.0000161144.98350.28","article-title":"Renal blood flow measurements with use of phase-contrast magnetic resonance imaging: normal values and reproducibility","volume":"16","author":"Bax","year":"2005","journal-title":"J Vasc Interv Radiol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925001302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925001302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:12:13Z","timestamp":1762632733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925001302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2589555925001302"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101452","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101452"}}